bpc-157 + kpv BPC Combo FDA panel backs compounded BPC-157,

For use as an aid in the management of vitamin B12 deficiencies in horses, dogs, and cats

Preclinical investigations indicate that the peptide may attenuate behavioral and functional disturbances in rodent models of neurodegeneration induced by neurotoxic agents such as MPTP and reserpine

The combination of documentation depth, identity verification, fulfillment transparency, and research-use-only framing places Koi at the top of the Canadian BPC-157 supplier list for 2026

If you have been diagnosed with any of these issues, consulting with a spine specialist about appropriate treatment options remains essential

Using plain water for a sticky peptide

Doing so enables stabilization of the peptide